Mediclinic International PLC (LON:MDC) had its price objective trimmed by Jefferies Group from GBX 812 ($10.07) to GBX 741 ($9.19) in a report released on Tuesday. The firm currently has a hold rating on the stock.

A number of other analysts have also weighed in on the stock. Credit Suisse Group AG cut their target price on shares of Mediclinic International PLC from GBX 1,120 ($13.89) to GBX 1,045 ($12.96) and set an outperform rating on the stock in a research report on Friday, November 11th. JPMorgan Chase & Co. restated a neutral rating and issued a GBX 1,160 ($14.39) target price on shares of Mediclinic International PLC in a research report on Tuesday, August 23rd. HSBC cut their target price on shares of Mediclinic International PLC from GBX 920 ($11.41) to GBX 745 ($9.24) and set a reduce rating on the stock in a research report on Friday, November 11th. Macquarie cut their target price on shares of Mediclinic International PLC from GBX 970 ($12.03) to GBX 830 ($10.30) and set a neutral rating on the stock in a research report on Wednesday, November 23rd. Finally, Citigroup Inc. lowered shares of Mediclinic International PLC to a neutral rating and set a GBX 1,090 ($13.52) target price on the stock. in a research report on Monday, September 12th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. Mediclinic International PLC currently has a consensus rating of Hold and a consensus target price of GBX 933.33 ($11.58).

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Shares of Mediclinic International PLC (LON:MDC) opened at 710.50 on Tuesday. The company’s market cap is GBX 5.24 billion. Mediclinic International PLC has a 52-week low of GBX 704.00 and a 52-week high of GBX 1,174.00. The company has a 50 day moving average of GBX 845.21 and a 200-day moving average of GBX 949.09.

ILLEGAL ACTIVITY NOTICE: This news story was published by Daily Political and is the propert of of Daily Political. If you are accessing this news story on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The original version of this news story can be viewed at http://www.dailypolitical.com/2016/11/30/mediclinic-international-plc-mdc-price-target-lowered-to-gbx-741-at-jefferies-group.html.

The firm also recently declared a dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 24th will be issued a dividend of GBX 3.20 ($0.04) per share. The ex-dividend date is Thursday, November 24th. This represents a dividend yield of 0.41%.

In other Mediclinic International PLC news, insider Alan Grieve purchased 1,152 shares of the business’s stock in a transaction dated Monday, November 28th. The shares were bought at an average price of GBX 734 ($9.11) per share, for a total transaction of £8,455.68 ($10,489.62).

About Mediclinic International PLC

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.